GRETIFAY
Live / Applied — Third extension granted (statement of use) (as of 11 Oct 2025)
What this means for you
Not registered yet, but its 26 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97909412
- Mark type
- Stylized text
- Filed
- 26 Apr 2023
- Published for opposition
- 05 Mar 2024
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2025 — SOU EXTENSION 3 GRANTED
- 10 Oct 2025 — SOU EXTENSION 3 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2025 — SOU EXTENSION 2 GRANTED
- 29 Apr 2025 — SOU EXTENSION 2 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2024 — REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED